微电生理(688351.SH)：一次性使用压力监测心脏脉冲电场消融导管获批上市

Core Viewpoint - The company has received registration approval from the National Medical Products Administration for its single-use pressure monitoring cardiac pulsed electric field ablation catheter, enhancing its product portfolio in arrhythmia treatment [1] Group 1: Product Development - The newly approved product utilizes a strain gauge-based pressure sensor design combined with pulsed electric field technology, magnetic field positioning technology, and saline infusion technology [1] - This catheter is designed to work in conjunction with cardiac pulsed electric field ablation devices for arrhythmia treatment [1] Group 2: Market Positioning - The product can provide real-time measurement of contact pressure between the catheter tip and the heart wall, as well as positional information within the heart when used with a three-dimensional cardiac electrophysiology mapping system [1] - The registration of this medical device allows the company to synergize its three major ablation energy products: radiofrequency, cryoablation, and pulsed electric field, thereby offering more treatment options for arrhythmia [1] - This development is expected to enhance the company's core competitiveness and market expansion capabilities [1]